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Abstract
Background: Non-neuronal cells, including those derived from lung, are reported to express
nicotinic acetylcholine receptors (nAChR). We examined nAChR subunit expression in short-term
cultures of human airway cells derived from a series of never smokers, ex-smokers, and active
smokers.
Methods and Results: At the mRNA level, human bronchial epithelial (HBE) cells and airway
fibroblasts expressed a range of nAChR subunits. In multiple cultures of both cell types, mRNA was
detected for subunits that constitute functional muscle-type and neuronal-type pentomeric
receptors. Two immortalized cell lines derived from HBE cells also expressed muscle-type and
neuronal-type nAChR subunits. Airway fibroblasts expressed mRNA for three muscle-type
subunits (α1, δ, and ε) significantly more often than HBE cells. Immunoblotting of HBE cell and
airway fibroblast extracts confirmed that mRNA for many nAChR subunits is translated into
detectable levels of protein, and evidence of glycosylation of nAChRs was observed. Some minor
differences in nAChR expression were found based on smoking status in fibroblasts or HBE cells.
Nicotine triggered calcium influx in the immortalized HBE cell line BEAS2B, which was blocked by
α-bungarotoxin and to a lesser extent by hexamethonium. Activation of PKC and MAPK p38, but
not MAPK p42/44, was observed in BEAS2B cells exposed to nicotine. In contrast, nicotine could
activate p42/44 in airway fibroblasts within five minutes of exposure.
Conclusions: These results suggest that muscle-type and neuronal-type nAChRs are functional in
airway fibroblasts and HBE cells, that prior tobacco exposure does not appear to be an important
variable in nAChR expression, and that distinct signaling pathways are observed in response to
nicotine.
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Background
Nicotine, the addictive component of tobacco smoke, sig-
nals through its family of receptors, the nicotinic acetyl-
choline receptors (nAChR). Acetylcholine is the
endogenous ligand for these receptors, and has been
found in many tissues outside of the nervous system.
Non-neuronal nAChR have also been identified in tissues
such as the skin, vasculature, and nasal mucosa [1].
nAChR are pentamers that form ion channels permeable
to either calcium or sodium. There are several types of
nAChR, which are defined by the subunit composition of
the receptor. Receptors contain all α-subunits, a combina-
tion of α and β subunits, or α, β, ε/γ, and δ subunits [2].
Heteropentamers have been classified as either muscle
nAChR, which were first identified at the neuromuscular
junction, or as neuronal type, which were discovered in
the central nervous system. Homopentamers were also
discovered in the CNS and are also considered to be neu-
ronal-type receptors. The adult muscle type receptor con-
tains the α1/β1/ε/δ subunits, with the β1 subunit
occurring twice to make the pentamer. The neuronal het-
eropentamers occur with several different specific subu-
nits, but always with three α and two β subunits,
numbered α2 through α6 and β2 through β4. The homo-
pentamer that has been characterized most completely is
the  α7 pentamer, although recently others have been
identified (α8, α9, and α10). The α9 and α10 subunits are
unique in that they can form functional homopentamers
or can combine together to form a heteropentamer with-
out a β subunit. They are also different from the other sub-
unit combinations examined because nicotine acts as a
competitive antagonist to receptors containing the α9
subunit [3].
The ionic permeability of nAChR is dependent upon the
subunit composition of the receptor, with some receptors
showing preference to either calcium or sodium [4]. How-
ever, regardless of initial preference, stimulation of all
nAChR by agonist are thought to lead to a calcium influx,
either directly through the nAChR channel or due to a
change in membrane potential that leads to the opening
of calcium L-channels [4]. Extended exposure of nAChR
to agonist can lead to receptor inactivation [5]. Again, the
degree and severity of inactivation depends upon the sub-
unit composition of the receptor [5].
The primary route of exposure to nicotine is through inha-
lation, either by active smokers or non-smokers exposed
to environmental tobacco smoke. Through inhalation,
the lung, in particular, would be exposed to pharmacolog-
ical doses of nicotine. In addition, receptor inactivation is
likely to occur in sensitive receptors, due to the extended
length of time that smokers use tobacco [2,5]. This could
lead to changes in receptor expression over time; in the
brain, it has been noted that the type of nAChR expressed
is different in smokers than in never smokers.
Using radiolabeled agonist, we have shown that saturable
nicotine binding sites exist in the lung [6]. Other previous
studies of the airways exposed to nicotine have shown
changes in expression of collagen [7]. In vitro data has
indicated that airway epithelial cells release GM-CSF upon
exposure to nicotine, and activate Akt, a signaling molec-
ular important in cell survival [8,9]. However, although a
number of different nAChR subunits are reportedly
expressed at the mRNA in human airway cells, [9-12] air-
way tissue has not been examined for the presence of neu-
ronal-type nAChR at the protein level or for the muscle-
type nAChR at the mRNA or protein levels. It is also not
known if particular nAChR are more likely to signal
through particular downstream pathways when more
than one receptor type is present, if the nAChR present in
the airway changes after long-term exposure to nicotine,
or if calcium influx is responsible for downstream
signaling.
In this study, a series of 37 short-term human bronchial
epithelial cultures, 25 airway fibroblast cultures, and 2
immortalized bronchial epithelial cell lines were exam-
ined by RT-PCR for nAChR expression. We also examined
protein expression by immunoblot to determine which
subunits are most highly expressed and to determine if
appropriate combinations are present at the protein level
to form functional receptors. We determined that the
nAChR present are functional by examining calcium
influx after agonist exposure, and blockade by antago-
nists. We also show that exposure of airway cells to nico-
tine leads to activation of downstream signaling
pathways. Finally, we examined the nAChR present in
HBE and airway fibroblasts derived from smokers, ex-
smokers, and never smokers to determine if alterations in
nAChRs based on tobacco exposure can be detected.
Methods
Primary Airway Cell Culture
HBE cells are cultured from airway biopsies using stand-
ard methodology in serum-free medium [13]. Briefly,
biopsies are taken from the carina in an area that is nor-
mal by appearance by white light bronchoscopy and con-
firmed using LIFE bronchoscopy. Biopsies are teased apart
with forceps and HBE cells are cultured in BEGM (Cam-
brex Biosciences, Walkersville, MD) for a maximum of
two passages on collagen IV coated flasks. This medium is
selective for bronchial epithelial cells and at the first pas-
sage, cultures are examined and contain 95% or greater
epithelial cells. Human airway fibroblasts are derived
from bronchial tissue that is minced with scalpels and cul-
tured in DMEM with 10% bovine serum. HBE cells cannot
be propagated in this medium. Biopsies were obtainedRespiratory Research 2004, 5:27 http://respiratory-research.com/content/5/1/27
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during surgical thoracic resection or bronchoscopy proce-
dures from normal areas of the upper airway. All tissue
donors gave informed consent under an approved IRB
protocol and answered questionnaires regarding tobacco
exposure.
Airway Cell lines
BEAS2B were all purchased from ATCC and cultured
according to ATCC instructions. IB3-1 cells were derived
from a cystic fibrosis patient and cultured in Hams
medium with 10% serum [14].
Supplies
All chemicals used were from Sigma (St. Louis, MO) and
all supplies were from either Fisher Scientific (Pittsburgh,
PA) or PGC Scientific (Frederick, MD), unless otherwise
indicated.
RNA and Protein Isolation
RNA is isolated from cultures using standard guanidinium
thiocyanate method [15]. RNA is quantitated using the
absorbance at 260 nM and purity is determined using the
A260/A280 ratio. After RNA is isolated from the aqueous
phase of the solution, protein is extracted from the
organic phase, using the method recommended by Invit-
rogen for the isolation of protein from Trizol. The protein
pellet is resuspended in 1% SDS with protease and phos-
phatase inhibitors added and stored at -80°C. Alterna-
tively, if RNA was not taken from the sample, protein was
analyzed from whole cell lysates. Airway cells were
Table 1: RT-PCR Primers and Conditions
Primer Optimal Annealing Temperature Product Size Sequence
alpha 1* 55 580/505 CGT TCT GGT GGC AAA GCT
CCG CTC TCC ATG AAG TT
alpha 2* 55 466 CCG GTG GCT TCT GAT GA
CAG ATC ATT CCA GCT AGG
alpha 3 58 464 CTG GTG AAG GTG GAT GAA GT
CTC GCA GCA GTT GTA CTT GA
alpha 4 58 444 GGA TGA GAA GAA CCA GAT GA
CTC GTA CTT CCT GGT GTT GT
alpha 5* 55 525 GAT AAT GCA GAT GGA CGT
TGA TGG TAT GAT CTC TTC
alpha 6 58 372 GTG GCC TCT GGA CAA GAC AA
CCT GCA GTT CCA AAT ACA CA
alpha 7 58 375 GGA GCT GGT CAA GAA CTA CA
CAG CGT ACA TCG ATG TAG CA
beta 1 58 479 CTA CGA CAG CTC GGA GGT CA
GCA GGT TGA GAA CCA CGA CA
beta 2 62 453 CAA TGG CTC TGA GCT GGT GA
CCA CTA GGT GTG AAG TCG TCC A
420 GGC TCT GAG CTG GTG ACA GTA
CAC CTC ACT CTT CAG CAC CA
beta 3 62 439 TGGAGA GTA CCT GCT GTT CA
CGA GCC TGT TAC TGA CAC TA
beta 4 58 524 GTG AAT GAG CGA GAG CAG AT
GGG ATG ATG AGG TTG ATG GT
delta 58 471 CAG ATC TCC TAC TCC TGC AA
CCA CTG ATG TCT TCT CAC CA
426 CAA CGT GCT TGT CTA CCA CTA C
GGT AGG TAG AAG ACC AGG TTG A
gamma 546 CGC CTG CTC TAT CTC AGT CA
GGA GAC ATT GAG CAC AAC CA
epsilon 55 432 GTA ACC CTG ACG AAT CTC AT
GTC GAT GTC GAT CTT GTT GA
* From Maus et al. [12]
Unique primers to each nAChR subunit were used in PCR reactions. All results were sequenced and compared to the known subunit sequences to 
confirm that the correct subunit was being amplified.Respiratory Research 2004, 5:27 http://respiratory-research.com/content/5/1/27
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scraped into RIPA buffer (150 mM NaCl, 50 mM Tris, pH
7.4, 5 mM EDTA, 1% igepal, 0.5% SDS, 1% deoxycholate)
with protease inhibitors 10 µg/ml PMSF, 30 µl/ml apro-
tinin, and phosphatase inhibitor 1 mM sodium
orthovanadate. Lysates were store at -80°C. All protein
was quantitated using the BCA assay (Pierce, Rockford IL).
RT-PCR of nAChR
Primers were developed to unique regions of each subunit
and were tested on human muscle and brain RNA pur-
chased from Clontech (Palo Alto, CA). Optimized proto-
cols were then used on RNA from airway cells. All primers
span introns and do not amplify DNA. GAPDH or actin is
always used as a positive control for RNA integrity. Oligo
dT12–18 (Invitrogen) was annealed to 1 µg total RNA and
reverse transcribed with Superscript II (Invitrogen). The
reaction contained 1 µg RNA, 500 ng Oligo dT12–18, 50
mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl2, 10 mM
DTT, 1 mM each dNTP, 200 U superscript. Briefly, total
RNA was incubated with oligo dT12–18 at 70°C for 10 min.
The cDNA produced was then used as a template for PCR
using specific primers. Table 1 indicates the primer used
and optimized conditions for each subunit. PCR amplifi-
cation was performed in a 20 µl reaction containing 2 µl
of the RT reaction, Taq DNA polymerase (Perkin Elmer),
1X PCR buffer, 1.5 mM MgCl2, 1 mM each dNTP and 1
µM primer. PCR was carried out in a Perkin-Elmer 9700
Thermocycler with 2 min, 95°C denaturation, followed
by 30 cycles of 94°C for 30 s, 55°-62°C (see table 1) for
30 s and 72°C for 30 s. Final extension was at 72°C for 5
min. 10 µl of each reaction was run on a 1% TBE gel for
analysis. β2 and δ subunits were detected using nested
PCR. Primary PCR reactions were carried out as described
above. 2 µl of the primary reaction was used as the tem-
plate for the secondary PCR reaction/second round PCR.
Thirty rounds of PCR were carried out at the temperatures
listed in Table 1.
Immunoblotting of nAChR
50 µg protein with loading buffer was denatured using 50
mM DTT and heated at 80°C for 15 min. Protein was
loaded onto 10% Bis-Tris gels (Invitrogen). Brain lysate
(US Biologicals) and lysates from myotubes cultures (gift,
Z.Z. Wang, U. Pittsburgh) were used for positive control.
Protein was transferred to PVDF (Biorad, Hercules, CA) or
Multiblots (ISC Bioexpress, Kaysville, UT). PVDF mem-
branes were blocked for 1 hr with 5% blocker (Biorad) in
TBS-T (2.7 mM KCl, 138 mM NaCl, 20 mM Trizma, pH
7.4, 0.1% Tween-20 (Biorad)). Primary antibody was
diluted in carrier protein, 5% blocker for PVDF or 0.5%
casein (Pierce) for Multiblots and incubated at 4°C over-
night, see Table 2 for details. After 4 washes with TBS-T,
blots were incubated with appropriate HRP-linked sec-
ondary antibody (Santa Cruz, Santa Cruz, CA) at the dilu-
tion recommended by the manufacturer for 1 hr in carrier
protein as previously. Following 4 more washes with TBS-
T, ECL was then done (ECL kit, Amersham Biosciences).
Calcium influx assay
Airway cells were grown in 24-well dishes, with 10,000
cells per well. After 24 hours, medium was replaced with
serum-free, prewarmed medium spiked with calcium-45,
with a final specific activity of approximately 60 µCi/mM
calcium. Drug was added to the wells as indicated, in trip-
licate. If nAChR antagonists or channel blockers were
used, they were added 20 min before the addition of ago-
nist. The calcium ionophore A23187 (Molecular Probes,
Eugene OR) was used as a positive control for calcium
influx. After incubation at 37°C, plates were put on ice
and washed 3 times with ice-cold PBS. Lysis buffer (1%
SDS, 0.3 N NaOH) was added. Lysates were transferred to
scintillation vials, scintillation fluid added, and counted.
Results are presented as percent control, with untreated
control normalized to 100%.
Phospho-protein Immunoblotting
For phospho-PKC, phospho-p42/44, and phospho-p38,
10 minute exposure to 20 ng/ml EGF was used as the con-
trol. These conditions have been published as optimal for
signaling by EGF in several published articles [16,17].
Immunoblotting for phospho-proteins was done by run-
ning 30 µg protein, reduced by heating to 80°C for 15
min in the presence of 50 mM DTT, on a 10% Tris-Bis gel
(Invitrogen). Protein was transferred to PVDF then
blocked with 5% blocker (Biorad) in TBS-T 1 hr. Antibody
was diluted 1:1000 in 5% blocker as directed by Cell Sig-
naling, Inc. and rocked overnight, 4°C. Membranes were
then washed four times and probed with appropriate
HRP-linked antibody (Santa Cruz) 1:5000 for 1 hr. After
four TBS-T washes, ECL was done (Amersham). Results
were normalized for loading differences by stripping with
ImmunoPure IgG elution buffer (Pierce, Rockford IL) for
Table 2: nAChR Antibodies and Conditions
Subunit Company Dilution
alpha-1 Sigma 1:30,000
alpha-2 Santa Cruz 1:1000
alpha-3 Santa Cruz 1:2000
alpha-4 Santa Cruz 1:1000
alpha-5 Sigma 1:15,000
alpha-7 Sigma 1:30,000
beta-1 Sigma 1:10,000
beta-2 Santa Cruz 1:1,000
delta Wang et al. [30] 1:4000
Antibodies specific to particular nAChR subunits were purchased 
from either Santa Cruz or Sigma. Antibody specific to the δ subunit 
was a gift from Dr. Zhu-Zhong Wang, University of Pittsburgh.Respiratory Research 2004, 5:27 http://respiratory-research.com/content/5/1/27
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3 hours at 37°C, then probing for β-actin using an HRP-
linked anti-β-actin antibody (Santa Cruz).
Statistical Analysis
Differences in expression frequency of nAChR subunits at
either the RNA or protein level were analyzed by Fisher's
Exact Test. In all other experiments, differences from con-
trol were determined using Student's T-test. All p-values
reflect two-tailed tests.
Results
Neuronal and muscle-type nAChR are present on HBE 
cells and airway fibroblasts
Using RT-PCR, we repeatedly detected mRNA for nAChR
subunits in short-term cultures of human airway cells
from bronchial biopsies. Figure 1 shows representative
PCR products from two HBE cultures (Panel E and F), one
airway fibroblast culture (Panel D), and immortalized
HBE BEAS2B cells (Panel C). Brain mRNA was used as a
positive control for neuronal-type nAChR (Figure 1 Panel
A) and muscle mRNA as a positive control for muscle-type
nAChR (Figure 1 Panel B), and GAPDH is included on
each panel to indicate mRNA quality. A water-only sam-
ple was used as a negative control in each experiment.
PCR products were found at the expected size for each
subunit and were sequenced and compared to the known
gene sequences, and confirmed to be the expected
sequence for each subunit. HBE cells cultured from airway
biopsies from a series of never smokers, ex-smokers, and
active smokers were examined by RT-PCR and the results
are summarized in Table 3. Due to limited RNA yield,
some samples were not examined for all possible subu-
nits. We found that seven different nAChR subunits were
expressed in over 50% of the sample examined, including
α5, α6, α7, α9, β1, δ and ε. Three additional subunits, α1,
α3, and β4 were expressed in at least 30% of cultures
examined. The α2 and α4 subunits were also examined,
but were never present (data not shown).
The subunits that are expressed by HBE cells could poten-
tially combine to form muscle-type (α1/ β1/ δ /ε) hetero-
pentamers, neuronal α7 or α9 homopentamers, and
neuronal heteropentamer receptors α3/ α5/ β2 or β4 and
α6/β2 or β4. By examining the pattern of mRNA expres-
sion in each individual culture, combinations were
observed that would produce a functional muscle-type
receptor in 7 of 33 (21%) of cultures, a functional α3-con-
Table 3: Expression of nAChR in HBE and Bronchial Epithelial Cells Lines as determined by RT-PCR
HBE α1 α3 α5 α6 α7 α9 β1 β2 β3 β4 * δε
Never smoker 2/9 
(22%)
2/8 
(25%)
6/9 
(67%)
5/9 
(56%)
7/9 
(78%)
8/8 
(100%)
9/9 
(100%)
4/7 
(57%)
0/8 
(0%)
6/9 
(67%)
7/8 
(88%)
5/9 
(56%)
Active smoker 3/10 
(30%)
0/3 
(0%)
9/10 
(90%)
3/4 
(75%)
7/10 
(70%)
3/3 
(100%)
9/10 
(90%)
5/9 
(56%)
0/5 
(0%)
1/10 
(0%)
6/8 
(75%)
7/10 
(70%)
Ex-smoker 7/18 
(39%)
8/19 
(42%)
18/19 
(95%)
9/19 
(47%)
11/18 
(61%)
16/18 
(89%)
17/19 
(89%)
6/16 
(38%)
1/19 
(5%)
9/19 
(47%)
11/18 
(61%)
10/19 
(53%)
Total 12/37 
(32%)
10/30 
(33%)
33/38 
(87%)
17/32 
(53%)
25/37 
(68%)
27/29 
(93%)
35/38 
(92%)
15/32 
(47%)
1/32 
(3%)
16/38 
(42%)
24/34 
(70%)
22/38 
(58%)
BEAS2B +-++++++-+++
IB3-1 +-+-++++-+++
nAChR subunits present in HBE and bronchial epithelial cell lines as determined by RT-PCR. The table indicates the number of positive cultures out 
of the total number of cultures examined, as well as the percentage of positive cultures for each subunit. * indicates statistical significance when 
comparing cultures from never smokers to those of active or ex-smokers.
Expression of nAChR subunits from cell types by RT-PCR Figure 1
Expression of nAChR subunits from cell types by RT-
PCR. A) Brain; B) Muscle; C) BEAS2B cell line; D) normal 
airway fibroblasts; E) human bronchial epithelial cells; F) 
human bronchial epithelial cells. On each panel, the brightest 
band on the 100 bp ladder represents 600 bp.Respiratory Research 2004, 5:27 http://respiratory-research.com/content/5/1/27
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taining neuronal type receptor in 10 of 28 (35%) of cul-
tures, α6-containing neuronal type receptor in 13 of 28
(46%), α7 homopentamer receptors in 25 of 37 (68%),
and homopentamer α9 receptors in 27 of 29 cultures
(93%). Only 2 of 35 (6%) HBE cultures did not express at
least one functional nAChR subunit combination.
Two immortalized airway epithelial cell lines also
expressed mRNA for many of these nAChR subunits,
including muscle-type subunits (Figure 1, Table 3).
BEAS2B, derived from normal HBE cells, and IB3-1,
derived from the bronchial epithelial cells of a cystic fibro-
sis patient, were examined. Both immortalized epithelial
cultures expressed the subunits required for a functional
muscle-type nAChR (α1/β1/δ/ε) and the homopentamers
α7 and α9, and BEAS2B cells express mRNA for subunits
that may combine to form functional neuronal nAChRs
(α6/ β2 or β4).
Airway fibroblasts also expressed nAChR (Table 4). We
found that mRNA for α1, α5, α6, α7, α9, β1, β2, δ and ε
were all expressed more than 70% of the time. All other
subunits were expressed less than one-third of the time. As
for HBE cells, we examined the pattern of mRNA expres-
sion in each airway fibroblast culture. nAChR subunits
could potentially combine to form muscle-type (α1/ β1/
δ / ε) receptors in 77% of fibroblast cultures and both neu-
ronal α7 or α9 homopentamers in 100% of cultures. Neu-
ronal heteropentameric nAChR containing the α6 subunit
might be formed in 59% of cultures, and neuronal heter-
opentamers containing the α3 subunit, with or without
the α5 subunit, could combine to form a functional recep-
tor in 27% of cultures.
The mRNA expression of four nAChR subunits is signifi-
cantly different when comparing airway fibroblasts and
HBE cells. The muscle-type receptor subunits α1, δ, and ε
are all expressed more frequently in airway fibroblasts
(present in 96%, 96%, and 92%, respectively, of airway
fibroblast cultures) than in HBE cells (α1 present in 32%
of cultures, δ in 70% of cultures, and ε present in 58% of
cultures, p < 0.02 for each subunit). In addition, the β3
subunit is also expressed more frequently in fibroblast
cultures than in HBE cells (8/25 compared to 1/28, p <
0.01). The subunit combinations that could form func-
tional receptors were also examined and compared
between cell types. Consistent with the individual subunit
data, the combination of all subunits for the muscle-type
receptor is expressed significantly more frequently in
human airway fibroblasts (74%) than in HBE cultures
(21%)(p = 0.0001).
The nAChR subunit α9 was frequently expressed by both
HBE cells and airway fibroblasts. Although we find this
nAChR frequently and it may have physiological signifi-
cance, it is unlikely that signaling through this receptor
would be responsible for the immediate downstream
effects seen in our studies, which focus on the effects of
nicotine, since nicotine does not act as an agonist for this
receptor type.
We next examined nAChR subunit protein expression
using immunoblotting. All the cultures examined
expressed protein for nAChR subunits, in general agree-
ment with mRNA expression data (for representative
results, see Figure 2, Figure 3). In these experiments,
whole brain and muscle tissue lysates as positive controls
(Figure 2, Figure 3). For each subunit, the culture was con-
sidered positive when a band matching the size of the pos-
itive control at the expected kilodalton size was found. A
doublet band just above the expected size on the blots
strongly suggests that both glycosylated and non-glyco-
sylated forms of the protein are present, and that protein
processing is in progress (Figures 2,3). Glycosylation is
essential for nAChR folding and expression on the cell
membrane, and the higher bands are expected. For the α3
Table 4: Expression of nAChR in Airway Fibroblasts as determined by RT-PCR
NLFB α1 α3 α5 α6 α7 α9 β1 β2 β3 β4 δε
Never smoker 5/5 
(100%)
2/5 
(40%)
5/5 
(100%)
5/5 
(100%)
5/5 
(100%)
5/5 
(100%)
5/5 
(100%)
5/5 
(100%)
2/5 
(40%)
2/5 
(40%)
5/5 
(100%)
5/5 
(100%)
Active smoker 10/11 
(91%)
3/11 
(27%)
11/11 
(100%)
8/11 
(73%)
10/11 
(91%)
11/11 
(100%)
11/11 
(100%)
8/11 
(73%)
4/11 
(36%)
2/11 
(18%)
10/11 
(91%)
10/11 
(91%)
Ex-smoker 9/9 
(100%)
0/9 (0%) 8/9 
(89%)
5/9 
(56%)
5/9 
(44%)
8/9 
(89%)
6/9 
(67%)
6/9 
(67%)
2/9 
(22%)
3/9 
(33%)
9/9 
(100%)
8/9 
(89%)
Total 24/25 
(96%)
5/25 
(20%)
24/25 
(96%)
18/25 
(72%)
20/25 
(80%)
24/25 
(96%)
22/25 
(88%)
19/25 
(76%)
8/25 
(32%)
7/25 
(28%)
24/25 
(96%)
23/25 
(92%)
nAChR subunits present in airway fibroblasts as determined by RT-PCR. The table indicates the number of positive cultures out of the total 
number of cultures examined, as well as the percentage of positive cultures for each subunit.Respiratory Research 2004, 5:27 http://respiratory-research.com/content/5/1/27
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subunit, bands below the expected size were observed
which might represent cross-reactivity of the antibody
with other nAChR subunits, or protein degradation prod-
ucts, but only those that matched the size of the brain con-
trol were considered a positive result. In HBE we found
that α1, β2, and δ were usually present (Figure 2A,2B).
Although there are also lower cross-reacting bands for
these nAChR subunits, a band of the correct size was also
frequently seen, and upper bands suggest that the
glycosylated form of the subunits are present (Figure
2A,2B). Protein for the subunits α4 and α7 were not
observed in HBE, and α3, α5, and β1 were sometimes
present, although α5 was expressed at a barely detectable
level compared to other subunits (Figure 2B).
To examine these findings more generally, nAChR protein
was examined in additional HBE cultures from never
smokers, active smokers, and ex-smokers (Table 5). Only
some of the cultures examined by immunoblot were
derived from the same individual as those we had exam-
ined by RT-PCR, so a direct comparison with the mRNA
expression results was not usually possible. Subunit pro-
tein expression is generally consistent with our previous
results, showing that the muscle-type receptor subunits
α1, β1, and δ are detected at the protein level and theoret-
ically form a functional receptor together with ε. Although
we have not found an antibody for ε that will detect this
protein in our positive controls, RT-PCR results indicate
that it is frequently expressed (Table 3).
One difference between our RT-PCR results and our
immunoblotting is in the frequency of α7 expression. α7
mRNA was expressed in 68% of our HBE cultures, but the
protein for this subunit was never detected, although the
protein was detected in positive controls and in airway
fibroblasts. This subunit is either transcribed but not
translated, or the protein may be expressed below the
limit of detection for immunoblotting in HBE cells.
We analyzed our protein data for combinations of subu-
nits that would form functional receptors. We found that
all three of the subunits needed for a functional muscle
receptor were highly expressed at the protein level in 44%
of the HBE cultures examined. The other functional com-
binations analyzed at the protein level are the neuronal
HBE and airway fibroblasts immunoblotting for nAChR subunits Figure 2
HBE and airway fibroblasts immunoblotting for nAChR subunits. Whole brain tissue lysate was used as a positive 
control. A) nAChR in HBE cells from never smokers; B) nAChR in HBE cells from ex-smokers; C) nAChR in airway fibroblast 
cells from one ex-smoker (1089), two never smokers (1133,1190), and three active smokers (1215, 1225, 1233). For each sub-
unit, the positive control band was seen at the following size: α1 55 kD, α3 60 kD, α4 70 kD, α5 53 kD, α7 56 kD, β1 59 kD, 
β2 57 kD, and δ 55 kD.Respiratory Research 2004, 5:27 http://respiratory-research.com/content/5/1/27
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α3-containing heteropentamers that were present in 33%
of the cultures.
We also determined that nAChR subunit protein is
expressed in airway fibroblasts (Figure 2). We found that
subunit expression had less variation among cultures
from different individuals in fibroblasts than HBE cul-
tures. The α1, α7, β2, and δ subunits were expressed in
100% of cultures. The α3,  α4, and α5 were never
expressed, and β1 was expressed in 83% of cultures. The
frequency of expression of α7 was significantly higher in
fibroblasts than HBE cultures (100% versus 0%, p <
0.0001), and α5 is more frequently expressed in HBE cul-
tures (54% versus 0%, p < 0.05).
We also found that nAChR subunit protein is expressed
on two cell lines derived from normal bronchial epithelial
cells described above (IB3-1, BEAS2B). Figure 3 is a repre-
sentative immunoblot and Table 5 contains the complete
table of results that have been repeated in independent
experiments. We find that both cell lines express α1, β1,
and δ protein. Therefore, the muscle-type (α1/ β1/ δ / ε) is
most likely the major functional nAChR on BEAS2B and
IB3-1. Neither cell line expresses protein for the α7 homo-
pentamer. BEAS2B cells also express protein for α5 and β2
but do not appear to have another appropriate het-
erodimer partner, such as α3, to produce a functional neu-
ronal nAChR. Based on the protein results, the only
pentameric nAChR receptor detected in the BEAS2B and
IB3-1 epithelial cell lines is the muscle-type
heteropentamer.
NAChR are functional in lung epithelial cells
We examined functionality of the AChR on HBE cells by
measuring calcium influx. After treatment with nicotine,
extracellular radioactive calcium (Ca-45) is internalized
by BEAS2B cells and short-term HBE cultures (Figure 4).
BEAS2B cells were chosen for these experiments instead of
IB3-1 due to the derivation of the cells. Since IB3-1 cells
were derived from a cystic fibrosis patient with the classic
sodium-channel defect, and nAChR can also act as
sodium channels, their expression or function may be
altered in this cell type due to abnormal ion levels. A
derivative of the calcium ionophore myomycin was used
as a positive control. Calcium-45 levels were 5 times over
control levels using the positive control (data not shown).
This high level of calcium influx is associated with loss of
membrane integrity caused by ionophore.
Expression of nAChR subunit protein by BEAS2B and IB3-1 Figure 3
Expression of nAChR subunit protein by BEAS2B and 
IB3-1. Immortalized bronchial epithelial cell lines BEAS2B 
and IB3-1 were immunoblotted for nAChR. For each subunit, 
the positive control band was seen at the following size: α1 
55 kD, α2 60 kD, α3 60 kD, α4 70 kD, α5 53 kD, α7 56 kD, 
β1 59 kD, β2 57 kD, and δ55 kD.Respiratory Research 2004, 5:27 http://respiratory-research.com/content/5/1/27
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The calcium influx seen in our experiments occurs within
5 minutes of treatment with nicotine and at concentra-
tions from 1 µM to 100 µM in both cell types. Calcium
influx was dose-dependent and reached 131% of control
in BEAS2B cells and 137% of control in HBE cells. At all
doses, influx of calcium-45 was statistically greater than
control in BEAS2B cultures (p < 0.05).
To test the specificity of this response, we used the nico-
tinic antagonists α-bungarotoxin and hexamethonium
with BEAS2B cells and nicotine. α-Bungarotoxin will
block muscle-type nAChR as well as α7 homopentamers
and hexamethonium will block neuronal heteropentamer
nAChR such as α3- and α6- containing receptors. We used
ionophore alone and with the nicotinic antagonists as a
control in these experiments. Antagonists had no effect on
ionophore-induced calcium influx (data not shown). In
Table 5: Expression of nAChR in HBE and Bronchial Epithelial Cell Lines as determined by Immunoblot
HBE α1 α3 α5* α7 β1 β2 δ
Never smoker 5/8 (63%) 1/4 (25%) 0/4 (0%) 0/4 (0%) 1/4 (25%) 3/5 (60%) 3/4 (75%)
Active 2/2 (100) n.d. 2+/2 (100%) 0/2 (0%) 2/2 (100%) 2/2 (100%) n.d.
Ex-smoker 5/7 (71%) 1/5 (20%) 5+/7 (71%) 0/7 (0%) 4/7 (57%) 5/5 (100%) 5/5 (100%)
Total 12/17 (71%) 2/9 (22%) 7/13 (54%) 0/13 (0%) 7/13 (54%) 10/12 (83%) 6/6 (100%)
BEAS2B +- +- +- +
IB3-1 +- +- +++
nAChR subunit protein present in HBE and bronchial epithelial cell lines as determined by immunoblot. The table indicates the number of positive 
cultures out of the total number of cultures examined, as well as the percentage of positive cultures for each subunit. * indicates statistical 
significance when comparing never smoking samples to combined active and ex-smoker samples. + The α5 subunit was present in these samples, but 
at low levels compared to other subunits and control.
Calcium influx after exposure of HBE or BEAS2B cells to nicotine Figure 4
Calcium influx after exposure of HBE or BEAS2B cells to nicotine. Intracellular calcium-45 was measured after expo-
sure to nicotine for 5 minutes. * statistically significant as compared to untreated control.Respiratory Research 2004, 5:27 http://respiratory-research.com/content/5/1/27
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this experiment we found that α-bungarotoxin could
completely prevent the calcium-45 influx seen after nico-
tine treatment, while hexamethonium could only slightly
inhibit the effect of nicotine in BEAS2B cells (Figure 5).
Based on this data, the neuronal nAChR α3- and α6- con-
taining receptors do not appear to play a significant role
in controlling calcium influx after nicotine treatment
since the inhibitor of this receptor type, hexamethonium,
could not significantly inhibit influx. Consistent with our
immunoblot data, the influx of calcium after exposure of
BEAS2B cells to nicotine is likely mediated through mus-
cle-type receptors (α1/β1/δ/ε), and can be blocked by the
inhibitor specific to these receptor types, α-bungarotoxin.
Signaling pathways are activated in response to nicotine
We determined if protein kinase C (PKC) responds to nic-
otine because it is commonly activated by calcium influx.
Calcium influx is an immediate effect of nicotine expo-
sure to BEAS2B cells (Figures 4 and 5). The mitogen-acti-
vated protein kinase (MAPK) family members p38 and
p42/44 were also examined because previous data
showed that nAChR may be involved in regulation of
apoptosis and growth [1,9]. In examination of PKC and
MAPK, cells were treated with epidermal growth factor
(EGF) as a positive control. We chose actin to correct for
total protein for densitometry so that we could probe
blots for a number of signaling pathways without com-
promising the protein on blots with unnecessary stripping
procedures.
Using phosphorylation as a marker of activation, we find
that PKC and p38, but not p42/44 are activated after treat-
ment with nicotine in BEAS2B (Figure 6). As shown in the
time course in Figure 6, phosphorylation of PKC is above
control levels at 15 minutes of continuous treatment and
stays above control through the longest time point, 60
minutes of continuous treatment. After correction for
total protein using actin, densitometry shows that PKC
levels are 120% of control after 1 minutes of exposure,
and after 60 minutes are 221% of untreated control. In
this experiment, a pan-phospho-PKC antibody was used
that detects six isoforms of phosphorylated PKC between
78 and 85 KD. P38 was also phosphorylated immediately
after nicotine treatment, with band intensity of 126% of
Calcium influx after exposure of BEAS2B cells in the presence of antagonist Figure 5
Calcium influx after exposure of BEAS2B cells in the presence of antagonist. BEAS2B cell were exposed to 1 µM 
nicotine in the presence or absence of nAChR antagonist. Intracellular calcium-45 was measured after exposure to nicotine for 
5 minutes. * statistically significant as compared to untreated control.Respiratory Research 2004, 5:27 http://respiratory-research.com/content/5/1/27
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Phosphorylation of proteins after nicotine exposure in BEAS2B cells Figure 6
Phosphorylation of proteins after nicotine exposure in BEAS2B cells. Nicotine causes phosphorylation of PKC and 
p38, but not p42/44 in BEAS2B cells. Cells were exposed to 100 µM nicotine for the times indicated. Panel A) represents the 
effect of nicotine on phosphorylation of PKC; B) represents the effect of nicotine on phosphorylation of p42/44; C) represents 
the effect of nicotine on phosphorylation of p38 D) is densitometry for the immunoblots expressed as percent of untreated 
control after correction with actin.Respiratory Research 2004, 5:27 http://respiratory-research.com/content/5/1/27
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control at the first timepoint examined, 5 minutes. Unlike
PKC, phosphorylation of p38 was only briefly present,
and phosphorylation drops to below control by 15
minutes of treatment. When probed for phospho-p42/44,
phosphorylation state was never above control in BEAS
2B through 60 minutes of treatment (Figure 6).
In contrast, signaling experiments done with short-term
airway fibroblast cultures show that nicotine caused phos-
phorylation of p42/44 within 10 minutes of exposure
(Figure 7). After densitometry and correction for loading
differences, phosphorylation was increased to 198% of
control at the 10 minute timepoint. Similarly to phospho-
rylation of p38 in BEAS2B cells, phosphorylation is tightly
controlled, and returns to below control levels by 30 min-
utes. Use of α-bungarotoxin showed that phosphoryla-
tion of p42/44 can be blocked by this nAChR antagonist
(data not shown), indicating that muscle-type and/or α7
receptors are involved in this response.
Together, these data indicate that the muscle-type (α1/β1/
δ/ε) nAChR is consistently present on airway epithelial
cells, while airway fibroblasts consistently demonstrate
both a muscle-type and an α7 homomeric nAChR.
Normal airway epithelial cells may also sometimes
express the neuronal α3/α5/β2 or α6/β2 nAChR. The nic-
Nicotine causes phosphorylation of p42/44 in airway fibroblasts Figure 7
Nicotine causes phosphorylation of p42/44 in airway fibroblasts. Cells were exposed to 100 µM nicotine for the times 
indicated. Panel A) represents the effect of nicotine on phosphorylation of p42/44; B) is densitometry for the immunoblots 
expressed as percent of untreated control after correction with actin.Respiratory Research 2004, 5:27 http://respiratory-research.com/content/5/1/27
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otinic receptors are functional, regulate calcium influx
upon ligand binding, and lead to downstream activation
of the signaling pathways MAPK or PKC when bound by
nicotine. Downstream effects can be blocked by use of
nicotinic antagonists.
Long-term nicotine exposure and nAChR expression
We examined the relationship of prior smoking to nAChR
expression on airway cells. To do so, we compared subu-
nits expressed at the mRNA and protein level in HBE cul-
tures from never smokers, active smokers, and ex-smokers
to determine if long-term exposure to nicotine was a fac-
tor in the type of nAChR expressed. As shown in Table 3,
comparison of HBE cultures from 9 never smokers and 10
active smokers indicates that active smoking was associ-
ated with a significant decrease in mRNA expression of the
β4 subunit (6 of 9 never smokers expressed this subunit
compared to 1 of 10 active smokers (p = 0.02). This differ-
ence was not significant when comparing active to ex-
smokers. In addition, frequency of expression in HBE cells
of other subunits that make up the neuronal nAChR was
not significantly different between active and never smok-
ers. At the protein level, our data show that α5 may be
upregulated in HBE cells at the protein level in response
to chronic nicotine exposure (Table 5). Fewer never-
smokers express α5 protein than ever-smokers (p < 0.05),
although at lower levels than its receptor partners. An
available antibody to the β4 subunit was not found to be
specific to that subunit in our controls, therefore we could
not determine if the β4 protein is modulated by tobacco
exposure, as observed at the mRNA level.
Interestingly, in airway fibroblasts mRNA patterns for
combinations of neuronal heteropentamers containing
the α3 subunit were downregulated with smoking (Table
4). Cultures containing mRNA for all the subunits to form
α3/ β2 or β4 receptors, with or without α5, were observed
in 80% of never-smokers, but only 25% of active smokers
and none of the ex-smokers examined. This difference was
significant when comparing never smokers to ex-smokers
or comparing never-smokers to ex- and active smokers
together (p < 0.01). However, when analyzing protein
results, no differences were found among active-, ex-, and
non-smokers in the projected receptor type.
Discussion
Recent evidence suggest that endogenous acetylcholine is
a local signaling molecule in non-neuronal tissue, and
that nicotinic acetylcholine receptors are found outside
the nervous system. Our data show that HBE cells can
express mRNA for the neuronal α3/α5/β2 or β4, α6/β2 or
β4, and α7 and α9 pentamers, as well as the muscle type
α1/β1/δ/ε nAChR. Previous data in the human airway
examined small numbers of HBE cultures for a limited
number of nAChR subunits. Maus et al. [12] used RT-PCR
and binding studies to show that the α3/α5/β2 nAChR
were present on HBE cells. West et al. [9] also character-
ized nAChR on three non-immortalized bronchial epithe-
lial cell lines and found the α3/α5/β2 nAChR subunits as
well as α7, α9, and α10. However, neither investigation
examined HBE cultures for the presence of the muscle-
type nAChR. West et al. [9] examined α1 mRNA expres-
sion by RT-PCR, which was negative, consistent with our
data that indicate that the mRNA for the α1 subunit is
expressed in approximately one-third of HBE cultures
from different individuals. In the present study, we have
determined that several types of nAChR are consistently
present on many primary cultures of HBE cells. Using a
panel of 38 HBE cultures for RT-PCR analysis, we find that
although not every nAChR subunit RNA is present in
every culture, the mRNA for seven different nAChR subu-
nits are consistently expressed in combinations that could
combine to form both muscle and neuronal-type recep-
tors. Immunoblotting confirmed that the nAChR mRNA
for these subunits was translated into detectable protein.
Not all subunits that are expressed at the mRNA level are
highly expressed at the protein level, indicating that some
regulation of nAChR expression may occur at the transla-
tional and post-translational levels. This has been previ-
ously shown in neuronal cells, where transcripts for the
α7 subunit are present even on cells without functional
α7 receptors [18]. Our data indicate that this also occurs
in HBE cells, where α7 transcripts are frequently found,
but protein of the correct size is not. Thus the conclusion
in prior literature that various neuronal nAChR receptors,
including α7, are responsible for actions of nicotine in
HBE may not be definitive.
Instead, our results suggest that the muscle-type nAChR
present in HBE cells may have a functional role in HBE
cells that has not previously been considered. The muscle-
type receptor was more recently characterized than the
neuronal type and previous literature never examined
HBE cultures for the muscle-type receptor [9,10,12]. This
finding was further supported by the observation that two
immortalized cell lines derived from HBE also expressed
protein for the muscle-type receptors, while lacking the α7
homopentamer protein.
Similarly to HBE, mRNA and protein for nAChR subunits
are commonly expressed by airway fibroblast cultures.
Airway fibroblasts have never been examined for the pres-
ence of nicotinic receptors. Dermal fibroblasts have been
shown to express mRNA for some receptors, although
they were not examined for muscle-type receptors [19],
and gingival fibroblasts respond to nicotine by decreasing
expression of integrins and increasing expression of c-fos,
but they have not been characterized for nAChR [20-22].
We find that airway fibroblasts express all the subunits
required for muscle-type nAChR. In contrast to HBE, theseRespiratory Research 2004, 5:27 http://respiratory-research.com/content/5/1/27
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cells also express readily detectable protein for the α7
receptor in all the cultures examined. Therefore, in these
cells, the muscle-type receptor and the α7 neuronal
homopentamer are the major functional nAChR that may
be responsible for signaling initiated by nicotine. α7
receptors are less susceptible to inactivation in the long-
term presence of agonist, while muscle-type receptors are
more likely to undergo inactivation [23]. Therefore, in
cells with these different receptors, there may be differ-
ences in the initiation of downstream signaling pathways
especially in response to extended exposure to nicotine,
such as occurs in a chronic smoker.
Calcium influx is a hallmark of the opening of the nAChR
ion channel. An increase in intracellular calcium from the
extracellular milieu can occur either by a direct influx of
calcium through the nAChR channel, as occurs in α7
receptors, or by an influx of sodium that leads to depolari-
zation of the cell and the opening of L-channels, as occurs
after agonist binding to heteropentamer nAChR [24,25].
We determined that nAChR are functional in both
BEAS2B and HBE cells; treatment of cells with nicotine
leads to an influx of extracellular calcium. The influx of
calcium seen after nicotine treatment was similar in mag-
nitude to calcium influx seen in neuronal cells after acti-
vation of L-channels (144%) [26]. Additionally, we
differentiated between functional muscle-type receptors
and neuronal heteropentamer receptors. In BEAS2B cells,
calcium influx stimulated by nicotine was significantly
inhibited by a muscle/ α7 antagonist, but only slightly
inhibited by a neuronal heteropentamer antagonist. This
confirms the observation that the neuronal heteropen-
tamer nAChRs do not play a major functional role in the
response of BEAS2B cells to nicotine in our hands. Since
α7 protein was not detected in HBE or BEAS2B cells, the
muscle-type nAChR is more likely the major functional
receptor type.
Nicotine has previously been shown to affect signaling in
human airway cells, and acetylcholine, the endogenous
ligand, causes proliferation of HBE cells [1,9]. In our
experiments, nicotine initiated signaling pathways
involved in cell growth and apoptosis in both HBE cells
and airway fibroblasts. In BEAS2B cells, immediate
phosphorylation of PKC is likely due to calcium influx.
Calcium is a known cofactor for classical PKC activation
and is required along with binding to diacylglyerol (DAG)
for functional conformation. Phosphorylation of PKC,
consistent with activation, increases over time. This may
indicate that upregulation of other PKC cofactors, such as
DAG, may occur as downstream events after calcium
influx, leading to an enhanced PKC signal over time.
Over the same time period, the MAPK family member p38
but not p42/44 is phosphorylated, a required step for acti-
vation. The activation of p38 is associated with regulation
of apoptosis in response to cellular stress. The MAPK fam-
ily kinases, such as p38, are not known to be directly acti-
vated by calcium; however there are several indirect
pathways that lead to rapid phosphorylation of these
pathways. These include signaling through the calcium/
calmodulin-dependent protein kinases CaMKI, CaMKII,
and CaMKIV as well as the calcium-activated signaling
molecule PYK2.
This finding is in contrast to signaling activated by nico-
tine in airway fibroblasts. These cells phosphorylate p42/
44 immediately upon treatment with nicotine. Like p38,
p42/44 is not directly activated by calcium, but could be
phosphorylated by calcium-activated signaling molecules.
However, the pathways that lead to phosphorylation of
different MAPK family members in the two cell types in
response to nicotine have not been elucidated. It is possi-
ble that the nAChR type differences are responsible for the
differential MAPK effects. For example, the α7 receptor is
highly expressed on airway fibroblasts but not on HBE
cells. The additional nAChR type on these fibroblasts may
change the signaling pathways activated by cells in
response to nicotine. This is consistent with a previous
study by Jull et al [27]. This study showed that ligand
binding to the α7 nAChR in SCLC cells leads to activation
of p42/44 through Raf [27]. A similar pathway may be
activated by the binding of nicotine to the α7 nAChR in
airway fibroblasts.
Finally, we found that smoking had only modest effects
on nAChR expression in the airway. Previous studies in
the brain indicate that certain nAChR may be increased in
frequency in smokers as compared to non-smokers [28],
and a published experiment showed that there was an
increase in the α3 nAChR expressed in respiratory epithe-
lial cells in one smoker compared to one nonsmoker [10].
Due to the limited sample size in the study of lung cells, it
is impossible to know if this difference was due to individ-
ual variation or was a smoking-induced change, especially
when considering the variability of nAChR subunit
expression seen among individuals in our study. In this
study of HBE cultures using a panel of active smokers,
never smokers, and ex-smokers, there were some statisti-
cal differences in the mRNA and protein expression of
nAChR subunits in cultures derived from donors with dif-
ferent smoking histories, including the increased presence
of protein for an α5 subunit in smokers that could
combine with the α3 containing receptors and change the
calcium permeability [29]. However, the α5 subunit was
expressed at a much lower protein level than the α3/β2
subunits, and may only be present in some of the neuro-
nal-type receptors. Other changes that were documented
with smoking status did not occur in the major functional
nAChR of the cell type. Corresponding changes also didRespiratory Research 2004, 5:27 http://respiratory-research.com/content/5/1/27
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not occur in the other subunit partners that are necessary
for function, so the effect on overall functional receptor
expression was probably unchanged with smoking status
in HBE cells.
In contrast, there was a significant decrease in the fre-
quency of the expression of the functional combination of
subunits for the α3-containing receptors in airway fibrob-
lasts of smokers and ex-smokers compared to never-smok-
ers. This nAChR type is a sodium channel that undergoes
inactivation upon long-term exposure to agonist, and, in
airway fibroblasts, appears to be downregulated with
long-term exposure to nicotine. This change in receptor
expression remains even after exposure to nicotine ceases,
as evidenced by the reduced frequency of expression in ex-
smokers.
Conclusions
We have shown that short-term cultures of normal airway
fibroblasts as well as normal human bronchial epithelial
cells from a number of different human donors consist-
ently express functional nAChR and that these cell types
differ in the type of nAChR they express. It is likely that the
muscle-type nAChR plays a major role in the response of
HBE cells to nicotine, and that the neuronal heteropen-
tamers play a more minor role. Calcium influx as well as
initiation of downstream signaling pathways indicate that
receptors are functional and that both human bronchial
epithelial cells and airway fibroblasts respond to nicotine,
and those signaling responses may differ due to the
difference nAChR present on the cell type. Together, these
data suggest that exposure of the human airway to nico-
tine through tobacco smoke may have physiological con-
sequences on airway homeostasis involving both the
airway mucosa and the underlying submucosal mesen-
chymal cells. As such, nicotine may act to promote lung
disease by acting to change cell growth and apoptosis. In
airway fibroblasts this may leading to thickening of the
airway wall seen in the pathogenesis of COPD. In the
bronchial epithelium this may lead to preneoplasia or
development of frank cancer.
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